[시장보고서]아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 예측(-2030년) : 지역별 분석

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 예측(-2030년) : 지역별 분석 - 제품별, 용도별, 최종사용자별

Asia Pacific Fluorescence In-Situ Hybridization Imaging Systems Market Forecast to 2030 - Regional Analysis - By Product, Application, and End User

상품코드 : 1452562 해당 상품은 즉시 배송 가능합니다

리서치사 : The Insight Partners

발행일 : 2024년 01월

페이지 정보 : 영문 106 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,450

￦ 4,981,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,424,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,450

￦ 7,868,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 2022년 2억 1,760만 달러에서 2030년에는 4억 90만 달러로 성장할 것으로 예측되고 있습니다. 2022-2030년의 CAGR은 7.9%로 추정됩니다.

체외 진단에 대한 R&D 투자 증가로 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 성장 촉진

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 체외진단(IVD) 관련 연구개발(R&D) 활동에 대한 지속적인 투자에 힘입어 성장하고 있습니다. 세포 환경에서 특정 DNA 서열을 시각화할 수 있는 고유한 기능을 가진 FISH 기술은 현대 진단 생태계에서 특히 유전성 및 희귀질환의 검출에 있으며, 중요한 절차로 부상하고 있으며, IVD 분야의 R&D 자금이 급증하면서 연구자들이 간소화된 자동화 지원 기능을 갖춘 향상된 이미지를 제공할 수 있게 되었습니다. PNA FISH는 펩티드 핵산(PNA) 프로브를 이용해 FISH를 수행함으로써 보다 정확하고 신속한 진단을 가능하게 하는 펩티드 핵산(PNA) 프로브를 이용한 FISH를 구현할 수 있습니다.(PNA) 프로브를 이용한 새로운 진단법으로, 기존 염색 절차의 용이성과 PNA 프로브의 뛰어난 성능을 결합하여 전염성 질환을 신속하고 정확하게 진단할 수 있도록 합니다.

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 개요

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 예측 기간 중 가장 높은 CAGR을 기록할 것으로 예상됩니다. 이 지역 시장은 각국의 높은 암 유병률, 의료기기 산업을 개선하기 위한 정부의 구상, 견고한 의료기기 제조 등의 요인으로 인해 향후 수년간 급성장할 것으로 예상됩니다. 인도네시아, 인도, 중국의 배송 센터가 이 지역의 아웃소싱 서비스를 지원하고 있습니다. 또한 유전성 질환 및 감염성 질환 증가로 인해 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장의 성장이 크게 확대되고 있습니다.

아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 매출 및 2030년까지의 예측(금액)

아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 세분화

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 제품, 용도, 최종사용자, 국가별로 세분화되어 있습니다.

제품별로는 아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 장비, 소모품, 액세서리, 소프트웨어로 구분됩니다. 소모품 부문은 2022년 아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장에서 가장 큰 점유율을 차지했습니다.

용도별로는 아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 암 진단, 유전병 진단, 감염성 질환 진단, 기타로 분류되며, 2022년 아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장에서 암 진단 부문이 가장 큰 비중을 차지할 것으로 예상됩니다. 부문이 가장 큰 비중을 차지할 것으로 예상됩니다.

최종사용자별로 아시아태평양 형광 in-situ 하이브리다이제이션 이미징 시스템 시장은 진단 실험실, 계약 연구 기관, 제약 및 생명공학 기업, 기타로 분류됩니다. 하이브리다이제이션 이미징 시스템 시장에서 진단 실험실 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다.

국가별로는 아시아태평양 형광 In-Situ 혼성화 이미징 시장은 중국, 일본, 인도, 한국, 호주, 기타 아시아태평양으로 구분되며, 2022년 아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장은 중국이 주도했습니다. 이 지배적이었습니다.

Euroclone SpA, Tissuegnostics Gmbh, Agilent Technologies Inc, Abnova Taiwan Corp, Biogenex Laboratories Inc, Leica Biosystems Nussloch Gmbh, Metasystems Probes Gmbh, Bio-View Ltd, Thermo Fisher Scientific Inc 등은 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장에서 활동하는 주요 기업 중 일부입니다.

주요 시장 촉진요인
- 대상 질환의 유병률 상승
- 체외진단에 대한 연구개발 투자의 증가
주요 시장 억제요인
- 형광 In-Situ 하이브리다이제이션 이미징 시스템과 절차의 고비용
주요 시장 기회
- 형광 In-Situ 하이브리다이제이션 이미징의 기술 진보
향후 동향
- 형광 In-Situ 하이브리다이제이션 이미징 기술의 자동화와 디지털화
영향 분석

제5장 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 : 아시아태평양 시장 분석

아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 매출, 2022-2030년

제6장 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 - 2030년까지의 매출과 예측 : 제품별

서론
아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 2022년·2030년 매출 점유율(%) : 제품별
기기
소모품
부속품
소프트웨어

제7장 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 : 매출과 2030년까지의 예측 : 용도별

서론
아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 : 2022년·2030년 매출 점유율(%) : 용도별
암 진단
유전자 질환 진단
감염증 진단
기타

제8장 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 : 매출과 2030년까지의 예측 : 최종사용자별

서론
아시아태평양 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장, 2022년·2030년 매출 점유율(%) : 최종사용자별
진단 랩
계약 연구기관
제약회사와 바이오테크놀러지 기업
기타

제9장 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 : 국가별 분석

중국
일본
인도
호주
한국
기타 아시아태평양

제10장 아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장 업계 상황

서론
아시아태평양의 형광 In-Situ 하이브리다이제이션 이미징 시스템 시장에서의 성장 전략
무기적 성장 전략
유기적 성장 전략

제11장 기업 개요

TissueGnostics GmbH
Agilent Technologies Inc
Abnova Taiwan Corp
BioGenex Laboratories Inc
Leica Biosystems Nussloch GmbH
MetaSystems Probes GmbH
Bio-View Ltd
Thermo Fisher Scientific Inc
PerkinElmer Inc
Euroclone SpA

제12장 부록

KSA

영문 목차

영문목차

The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 217.6 million in 2022 to US$ 400.9 million by 2030. It is estimated to grow at a CAGR of 7.9% from 2022 to 2030.

Increasing R&D Investments in In-Vitro Diagnostics Fuel Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market

The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is driven by continued investments in research and development (R&D) activities related to in-vitro diagnostics (IVD). With its unique capability to visualize specific DNA sequences within cellular environments, the FISH technique has emerged as a key procedure in the modern diagnostics ecosystem, particularly in detecting genetic disorders and rare diseases. An upsurge in R&D funding in IVD has catalyzed transformative advancements in FISH imaging systems by allowing researchers to create cutting-edge platforms providing enhanced image quality with features supporting streamlined automation, culminating in more accurate and rapid diagnostic processes. PNA FISH, a novel diagnostic method that uses FISH with peptide nucleic acid (PNA) probes, combines the ease of traditional staining procedures with the exceptional performance of PNA probes to provide rapid and accurate diagnoses of contagious diseases, which makes PNA FISH suitable for routine application and enables clinical microbiology laboratories to report important information for patient therapy within a time frame that is not possible using classic biochemical methods.

Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Overview

The Asia Pacific Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is expected to register the highest CAGR during the forecast period. The regional market is expected to grow rapidly in the coming years due to factors such as high cancer prevalence rates in countries, government initiatives to improve the medical device industry, and robust medical device manufacturing. Delivery centers in Indonesia, India, and China typically support outsourcing services in this region. Additionally, the rising cases of genetic disorders and infectious diseases significantly expand the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market growth in Asia Pacific.

Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Segmentation

The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.

Based on product, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

In terms of application, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Based on end user, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

By country, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The China dominated the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Euroclone SpA, Tissuegnostics Gmbh, Agilent Technologies Inc, Abnova Taiwan Corp, Biogenex Laboratories Inc, Leica Biosystems Nussloch Gmbh, Metasystems Probes Gmbh, Bio-View Ltd, And Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Rising Prevalence of Target Disorders
- 4.1.2 Increasing R&D Investments in In-Vitro Diagnostics
4.2 Key Market Restraints:
- 4.2.1 High Cost of FISH Imaging Systems and Procedures
4.3 Key Market Opportunities:
- 4.3.1 Technological Advancements in Fluorescence in Situ Hybridization Imaging
4.4 Future Trends:
- 4.4.1 Automation and Digitalization of FISH Imaging Technique
4.5 Impact Analysis:

5. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Asia Pacific Market Analysis

5.1 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Instruments
- 6.3.1 Overview
- 6.3.2 Instruments: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Instruments: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Consumables
- 6.4.1 Overview
- 6.4.2 Consumables: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.1 Consumables: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Accessories
- 6.5.1 Overview
- 6.5.2 Accessories: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Software
- 6.6.1 Overview
- 6.6.2 Software: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer Diagnosis
- 7.3.1 Overview
- 7.3.2 Cancer Diagnosis: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Genetic Disease Diagnosis
- 7.4.1 Overview
- 7.4.2 Genetic Disease Diagnosis: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Infectious Disease Diagnosis
- 7.5.1 Overview
- 7.5.2 Infectious Disease Diagnosis: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Diagnostic Laboratories
- 8.3.1 Overview
- 8.3.2 Diagnostic Laboratories: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Contract Research Organization
- 8.4.1 Overview
- 8.4.2 Contract Research Organization: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Pharmaceutical and Biotechnological Companies
- 8.5.1 Overview
- 8.5.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Country Analysis

9.1 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
- 9.1.1 Overview
- 9.1.2 Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.1.1 Overview
    - 9.1.2.1.2 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.1.3 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.1.3.1 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
    - 9.1.2.1.3.2 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
    - 9.1.2.1.4 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.1.5 China Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.2 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Overview
    - 9.1.2.2.2 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.3 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.3.1 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
    - 9.1.2.2.3.2 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
    - 9.1.2.2.4 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.5 Japan Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.3.1 Overview
    - 9.1.2.3.2 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.3.3 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.3.3.1 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
    - 9.1.2.3.3.2 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
    - 9.1.2.3.4 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.3.5 India Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.4 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 Overview
    - 9.1.2.4.2 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.3 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.3.1 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
    - 9.1.2.4.3.2 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
    - 9.1.2.4.4 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.5 Australia Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.5.1 Overview
    - 9.1.2.5.2 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.5.3 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.5.3.1 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
    - 9.1.2.5.3.2 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
    - 9.1.2.5.4 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.5.5 South Korea Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.6 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 Overview
    - 9.1.2.6.2 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.3 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.3.1 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
    - 9.1.2.6.3.2 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
    - 9.1.2.6.4 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.5 Rest of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)

10. Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 TissueGnostics GmbH
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Agilent Technologies Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abnova Taiwan Corp
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 BioGenex Laboratories Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Leica Biosystems Nussloch GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 MetaSystems Probes GmbH
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Bio-View Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Thermo Fisher Scientific Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 PerkinElmer Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Euroclone SpA
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms